ImmunityBio, Inc. - 10-Q Filing
ImmunityBio, Inc. reports financial results for the third quarter ended September 30, 2026.
Tickers: $IBRX
More Regulatory news
- Applied Aerospace & Defense, Inc. - 10-Q Filing
- Palomar Holdings, Inc. - 8-K Filing
- UNITED GUARDIAN INC - 10-Q Filing
- Dare Bioscience, Inc. - 8-K Filing
- NEXGEL, INC. - 8-K Filing
- TEREX CORP - 8-K Filing
- Victory Capital Holdings, Inc. - 8-K Filing
- Nano Dimension Ltd. - 8-K Filing
- M-tron Industries, Inc. - 10-Q Filing
- M-tron Industries, Inc. - 8-K Filing